- Home
- SGLY vs SYRS Comparison
SGLY vs SYRS Comparison
Compare SGLY & SYRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGLY
- SYRS
- Stock Information
- Founded
- SGLY 2001
- SYRS 2011
- Country
- SGLY United States
- SYRS United States
- Employees
- SGLY N/A
- SYRS N/A
- Industry
- SGLY
- SYRS Biotechnology: Pharmaceutical Preparations
- Sector
- SGLY
- SYRS Health Care
- Exchange
- SGLY Nasdaq
- SYRS Nasdaq
- Market Cap
- SGLY 5.8M
- SYRS 5.7M
- IPO Year
- SGLY 2008
- SYRS 2016
- Fundamental
- Price
- SGLY $0.83
- SYRS $0.17
- Analyst Decision
- SGLY
- SYRS Hold
- Analyst Count
- SGLY 0
- SYRS 5
- Target Price
- SGLY N/A
- SYRS $3.00
- AVG Volume (30 Days)
- SGLY 3.3M
- SYRS 1.2M
- Earning Date
- SGLY 02-19-2025
- SYRS 03-26-2025
- Dividend Yield
- SGLY N/A
- SYRS N/A
- EPS Growth
- SGLY N/A
- SYRS N/A
- EPS
- SGLY N/A
- SYRS N/A
- Revenue
- SGLY $2,255,541.00
- SYRS $386,000.00
- Revenue This Year
- SGLY N/A
- SYRS N/A
- Revenue Next Year
- SGLY N/A
- SYRS N/A
- P/E Ratio
- SGLY N/A
- SYRS N/A
- Revenue Growth
- SGLY N/A
- SYRS N/A
- 52 Week Low
- SGLY $0.66
- SYRS $0.16
- 52 Week High
- SGLY $7.65
- SYRS $7.96
- Technical
- Relative Strength Index (RSI)
- SGLY 36.06
- SYRS 38.78
- Support Level
- SGLY $0.78
- SYRS $0.16
- Resistance Level
- SGLY $0.95
- SYRS $0.20
- Average True Range (ATR)
- SGLY 0.17
- SYRS 0.02
- MACD
- SGLY -0.00
- SYRS 0.01
- Stochastic Oscillator
- SGLY 18.80
- SYRS 35.75
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.